View in EDS

The Cost-Effectiveness of Frontline Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia: In Pursuit of Treatment-Free Remission and Dose Reduction.

Saved in:
Bibliographic Details
Title: The Cost-Effectiveness of Frontline Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia: In Pursuit of Treatment-Free Remission and Dose Reduction.
Authors: Metsemakers SJJPM; Department of Hematology, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands. Electronic address: Sanne.Metsemakers@radboudumc.nl., Hermens RPMG; Department of IQ Health, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands., Ector GICG; Department of Hematology, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands., Blijlevens NMA; Department of Hematology, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands., Govers TM; Medip Analytics, Nijmegen, Gelderland, The Netherlands; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands.
Source: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2025 Feb; Vol. 28 (2), pp. 224-232. Date of Electronic Publication: 2024 Dec 27.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4733 (Electronic) Linking ISSN: 10983015 NLM ISO Abbreviation: Value Health Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39732165
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Cost-Effectiveness of Frontline Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia: In Pursuit of Treatment-Free Remission and Dose Reduction.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Metsemakers+SJJPM%22">Metsemakers SJJPM</searchLink>; Department of Hematology, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands. Electronic address: Sanne.Metsemakers@radboudumc.nl.<br /><searchLink fieldCode="AU" term="%22Hermens+RPMG%22">Hermens RPMG</searchLink>; Department of IQ Health, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Ector+GICG%22">Ector GICG</searchLink>; Department of Hematology, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Blijlevens+NMA%22">Blijlevens NMA</searchLink>; Department of Hematology, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Govers+TM%22">Govers TM</searchLink>; Medip Analytics, Nijmegen, Gelderland, The Netherlands; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100883818%22">Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</searchLink> [Value Health] 2025 Feb; Vol. 28 (2), pp. 224-232. <i>Date of Electronic Publication: </i>2024 Dec 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100883818 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1524-4733 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210983015%22">10983015 </searchLink><i>NLM ISO Abbreviation: </i>Value Health <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39732165
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jval.2024.12.005
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 224
    Titles:
      – TitleFull: The Cost-Effectiveness of Frontline Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia: In Pursuit of Treatment-Free Remission and Dose Reduction.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Metsemakers SJJPM
      – PersonEntity:
          Name:
            NameFull: Hermens RPMG
      – PersonEntity:
          Name:
            NameFull: Ector GICG
      – PersonEntity:
          Name:
            NameFull: Blijlevens NMA
      – PersonEntity:
          Name:
            NameFull: Govers TM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2025 Feb
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1524-4733
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
              Type: main
ResultId 1